Greetings!
The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available. If you have a resource to include in our next issue, please send to Vanetta Thomas at vthomas@cami-health.org. Previous issues are available on the IMPT website.
Best,
IMPT Secretariat Staff
|
|
|
Announcements
The Initiative for MPTs (IMPT) invites you to join us
on Thursday, 26 January 2017 at 9:00 a.m. PT
/ 12:00 p.m. ET
for
the first in
a series of webinars
we will be hosting this year
to learn about critical issues in t
he rapidly developing MPT field: Bioavailability/Bioequivalence Strategies for MPTs - Feasibility and Risks
. This
webinar will feature
a presentation by Charles DiLiberti and a facilitated panel discussion with Laneta Dorflinger and Joseph Romano
. To register for the webinar click here.
|
|
Journal Articles
Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? Smith, J.A., Heffron, R., Butler, A.R., Celum, C., Baeten, J.M. Hallett, T.B. (2017, January). Contraception.
Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring. Externbrink, A., Eggenreich, K., Eder, S., Mohr, S., Nickisch, K., Klein, S. (2017, January). European Journal of Pharmaceutics and Biopharmaceutics, vol 110, 1-12.
The promise of multipurpose pregnancy, STI, and HIV prevention. Quaife, M., Terris-Prestholt, F., Vickerman, P. (2017, January). The Lancet Infectious Diseases, 17(1), 21-2.
|
Reports
Technical Meeting on Hormonal Contraceptives (HC) in MPTs. Hemmerling, A., McGrory, C.E., Dellplain, L., Romano, J., Young Holt, B. (2016, September 12). Initiative for Multipurpose Prevention Technologies (IMPT).
|
Presentations
The following presentations from the IMPT 2016 Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success are now available for viewing on the IMPT website:
- Cremin, I. - Increasing options for women - the potential impact of multipurpose prevention technologies for HIV prevention and contraception: a mathematical modelling study
- Friend, D. - Acidform Vaginal Gel Contraception and STI Prevention
- Merkatz, R. - Conducting Phase 3 MPT Studies - Considerations For Demonstrating Contraceptive Efficacy And Safety
- Rosenthal, S.Adolescent Psychological Development: Implications for Uptake of MPTs
- van der Straten, A. - How can we optimize adherence to products before, during and after phase III trials?
The following presentation from the IMPT 2016 Technical Meeting on Hormonal Contraception (HC) in MPTs is now available for viewing on the IMPT website:
- Kwon, D.A. - The role of the genital microbiome and injectable hormonal contraception in HIV acquisition in women
|
RFA-AI-16-085
Development of Multipurpose Prevention Technologies: A Strategy for the Prevention of Sexually Transmitted Infections (STIs) (R61/R33) - The NIH and NIAID will be accepting applications to support translational research focused on developing MPTs for prevention of STIs, HIV, and/or unintended pregnancy. Application due
March 15, 2017
.
|
|
|
|
|
